Q3's biggest healthcare deals: mRNA, digital care and cybersecurity

Listen
Text
  • Small
  • Medium
  • Large

The biggest healthcare deals in the third quarter of 2021 were for companies focused on mRNA drug discovery, digital care and cybersecurity, according to CB Insights' third-quarter venture capital report.

Here are the 10 biggest healthcare deals in 2021's third quarter:

  1. Chinese mRNA drugmaker Abogen raised $700 million in a series C funding round.

  2. Cambridge, Mass.-based mRNA drugmaker Laronde raised $440 million in a series B funding round.

  3. Columbus, Ohio-based healthcare automation company Olive raised $400 million in a series H funding round.

  4. Chinese artificial intelligence drug discovery company XtalPi raised $400 million in a series D funding round.

  5. Charlotte, N.C.-based care platform Cityblock Health raised $400 million in a series D funding round.

  6. San Francisco-based digital healthcare provider Carbon Health raised $350 million in a series D funding round.

  7. Chinese online insurance firm Zhiyuan Zhongan raised $309 million.

  8. Chinese healthcare payment and digital care platform MediTrust Health raised $308 million in a series C funding round.

  9. Santa Clara, Calif.-based cloud security provider Netskope raised $300 million in a series H funding round.

  10. Boston-based cyber defense platform developer Cybereason raised $275 million in a series F funding round.

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars